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Abstract We report the molecular cloning of a human cDNA
that encodes a molecule having striking homology with Ras-
specific GTPase-activating proteins (RasGAPs). Among pre-
viously described RasGAPs, the cDNA product is most closely
related to Caenorhabditis elegans GAP-2, including a predicted
coiled-coil structure near the carboxyl terminus. Expression of
the cDNA in Saccharomyces cerevisiae defective in one of two
RasGAPs, Ira2, complemented loss of the Ira2 function,
indicating that the cDNA product functions as a RasGAP. The
RasGAP-like gene is located on the human chromosome 1q25,
the locus that appears to contain a hereditary prostate cancer
susceptible gene, HPC1.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Since the ¢rst identi¢cation of Ras as a protooncogene
product whose mutations are involved in the transformation
of a variety of mammalian cells, accumulating evidence sug-
gests that Ras plays crucial roles in the control of cell growth
and di¡erentiation [1,2]. Ras is a membrane-associated pro-
tein that binds and hydrolyzes GTP to GDP [3]. By acting as
a molecular switch which cycles between the active GTP- and
the inactive GDP-bound states, Ras is thought to function as
a transducer of mitogenic signals.
The Ras-dependent signalling is controlled by two distinct
mechanisms, each of which involves regulatory molecules af-
fecting the GTP-GDP equilibrium: Ras guanine nucleotide-
releasing proteins (RasGNRPs) [4] and Ras GTPase-activat-
ing proteins (RasGAPs) [3]. RasGNRPs act as positive regu-
lators of Ras by exchanging GDP with GTP, whereas Ras-
GAPs negatively regulate Ras activity by stimulating the weak
intrinsic GTP-hydrolyzing activity of Ras.
There are four distinct RasGAPs so far identi¢ed from
mammalian cells ; p120GAP, neuro¢bromin, Gap1m, and
Gap1IP4BP [5^10]. One of these, neuro¢bromin, was originally
identi¢ed as a gene (NF1) product whose functional inactiva-
tion causes von Recklinghausen neuro¢bromatosis type 1 dis-
ease (NF1) [7,8]. Since NF1 is a cancer-prone disorder, neuro-
¢bromin is suspected to negatively regulate Ras-mediated
mitogenic signal transduction and hence prevent cellular
transformation [11,12].
RasGAPs have also been identi¢ed in lower eukaryotes.
Yeast S. cerevisiae possesses two RasGAPs termed Ira1 and
Ira2 [13^15]. Disruption of either the IRA1 or the IRA2 genes
leads to a phenotype that resembles that seen in cells contain-
ing constitutively active Ras. In particular, ira13 or ira23
strains are highly sensitive to heat shock and cannot survive
after heat shock treatment [13,14]. However, when RasGAP
molecules from mammalian cells are introduced and ectopi-
cally expressed in these ira3 cells, heat shock resistance is
acquired [16^18]. This demonstrates that RasGAPs are struc-
turally as well as functionally conserved throughout eukary-
otic evolution. RasGAPs have been also identi¢ed in Droso-
phila melanogaster [19] and in Caenorhabditis elegans (C.
elegans) [20,21]. All RasGAPs so far characterized share a
highly conserved domain called GAP-related domain
(GRD), which is required for the catalytic activity of RasGAP
[17].
In this work, we describe the molecular characterization
and chromosomal mapping of a human gene encoding a novel
protein, termed nGAP, having the GAP-related domain
(GRD) that is strongly conserved among RasGAPs.
2. Materials and methods
2.1. PCR-based cDNA cloning and plaque hybridization
5P-rapid ampli¢cation of cDNA ends (5P-RACE) was performed
with the use of a sequence-speci¢c reverse primer and a primer for
the VZAPII phage vector sequence by polymerase chain reaction
(PCR) using Taq polymerase. The PCR-ampli¢ed fragments were
ligated into pCRII vector and was used as a probe to screen human
heart cDNA library.
2.2. Reverse transcription-PCR analysis
Poly(A) RNA (0.5 Wg) from various tissues of adult ICR strain
mice was reverse transcribed by AMV reverse transcriptase with
cDNA Cycle Kit (Invitrogen). Subsequently, PCR was performed
for 30 cycles for 1 min at 94‡C, 2 min at 55‡C and 1 min at 72‡C,
employing the oligonucleotide primers for mouse nGAP, 5P-GTACC-
CAGTGAGTACACCC-3P and 5P-CTCCACAACGATCTACCTCT-
3P. The PCR product was subjected to electrophoresis in a 2% agarose
gel.
2.3. Plasmid construction
pKT10 is a S. cerevisiae expression vector which contains a glycer-
aldehyde-3-phosphate dehydrogenase (GPD) promoter. Other plas-
mids were constructed from pKT10 by introducing various cDNAs;
pKT18 contains a cDNA encoding Ira2-GRD (residues 1451^2255)
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[13^16]. pKP11 and pKP12 express neuro¢bromin-GRDs encompass-
ing residues 1063^1672 and residues 1063^1559, respectively. pNF201
contains a cDNA encoding neuro¢bromin-GRD encompassing resi-
dues (1063^1672) with Phe1434 to Leu mutation [22]. A series of cDNA
fragments encoding parts of nGAP were generated from the full
length nGAP cDNA and respectively subcloned into pKT10;
nGAP(298^1139) corresponding to residues 298^1139, nGAP(1^646)
corresponding to residues 1^646, nGAP(251^646) corresponding to
residues 251^646, nGAP(217^646) corresponding to residues 217^
646, and nGAP(150^646) corresponding to residues 150^646.
2.4. Yeast heat shock sensitivity assay
S. cerevisiae strains used for the assay were KT27-2B (MATa
ira2: :HIS3 ura3 leu2 trp1 his3) [14] and TK161-R2V (MATa ura3
leu2 trp1 his3 ade8 RAS2Val19) [22]. Heat shock sensitivity was deter-
mined as described previously [13]. Yeast strains were transformed
with various expression plasmids containing the URA3 gene and
were plated onto synthetic complete-uracil (SC-Ura) plates. Heat
shock sensitivity assay was performed by replica plating cells to a
plate followed by 15^45 min incubation at 55‡C. After heat shock
treatment, the plate was incubated for 3^4 days at 30‡C and photo-
graphed.
2.5. In vitro GAP assay
nGAP cDNA encoding residues 1^651 was ligated in frame with the
gene encoding glutathione S-transferase (GST) and was expressed
under the control of the GAL1 promoter in yeast S. cerevisiae. The
recombinant GST-nGAP(1^651) fusion protein was puri¢ed from the
galactose-induced yeast cell lysates by glutathione-Sepharose beads.
Small GTPases were puri¢ed from E. coli. Filter assays were per-
formed according to the method described previously [23]. The small
GTPase (1.5 ng) was incubated with 20 ng of either recombinant
Gap1m or GST-nGAP(1^651). After washing, radioactivity remaining
on the ¢lters was determined.
3. Results
3.1. Molecular cloning of cDNA encoding human nGAP
A fragment of cDNA, which predicted a protein with sig-
ni¢cant homology to GRD, was obtained during 5P-RACE
screening of a human heart cDNA library using the antisense
oligonucleotide primer (5P-CTCCACTGGAATTTGGACTG-
GAGT-3P) that corresponds to amino acid residues 501^508
(Asn-Ser-Ser-Pro-Asn-Ser-Ser-Gly) of human ELL2 RNA
polymerase II elongation factor [24]. The PCR fragment was
subsequently cloned into pCRII vector and used as a probe to
screen a human heart cDNA library and a cDNA containing
single large open reading frame was obtained. The cDNA
contained highly similar sequences with the ELL2 primer in
both nucleotide (5P-CTTCCACTGACATTTGGACTG-
GAGT-3P ; antisense) and amino acid (Asn-Ser-Ser-Pro-Asn-
Val-Ser-Gly) levels. However, there was no signi¢cant se-
quence homology between the two proteins other than the
above indicated amino acid stretches.
The putative open reading frame of the isolated cDNA
encodes 1139 amino acids with a calculated molecular mass
of 128 570 Da (Fig. 1A). A sequence homology search re-
vealed that the predicted protein exhibits substantial sequence
similarity (residues 298^621) to the catalytic domain of all
previously reported RasGAPs known as GRD (Fig. 2). Fur-
thermore, amino acid stretches between residues 124 and 158
and residues 169 and 251 show a weak homology to the
Pleckstrin-homology (PH) domain and the calcium/phospho-
lipid-binding (CALB) domain, respectively. Notably,
p120GAP, Gap1m and Gap1IP4BP possess both the PH do-
main and the CALB domain. Although the sequence similar-
ity to other RasGAPs is restricted to the GRD domain, the
cDNA product exhibits signi¢cant homology with a recently
identi¢ed RasGAP of C. elegans, GAP-2 [21], throughout the
entire protein sequence, sharing 31% amino acid sequence
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Fig. 1. The amino acid sequence and domain structure of nGAP.
A: Amino acid sequence of human nGAP deduced from the nucleo-
tide sequence of the cDNA. Putative GRD (residues 290^621),
which is predicted from sequence similarity between p120GAP and
neuro¢bromin, and the C-terminal region (residues 956^1120) that is
expected to form a coiled-coil structure are boxed, respectively. B:
Schematic representation of nGAP and the C. elegans RasGAP,
GAP-2 [21]. The black and gray boxes respectively represent the
GRD and the region that can form a coiled-coil structure.
Fig. 2. Multiple sequence alignment of GRDs of known RasGAPs
and nGAP. Sequence alignment of GRDs and consensus amino
acid sequences are shown. Highly conserved block 1, 2, 3A and 3B
are boxed. Source for sequences are C. elegans GAP-2 (residues
267^516), p120GAP (residues 705^953), neuro¢bromin (NF1) (resi-
dues 1188^1441), Gap1m (residues 307^561), Gap1IP4BP (residues
280^533), IRA1 (residues 1510^1756), IRA2 (residues 1656^1902)
and nGAP (residues 283^530).
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identity and 40% similarity (Fig. 1B). Furthermore, the two
proteins commonly possess a predicted coiled-coil structure at
the C-terminal region. Thus, the cloned cDNA encodes a new
RasGAP-like protein that appears to be a human homologue
of the C. elegans GAP-2 and hence we designated the protein
as nGAP (where n stands for nematode).
3.2. Tissue distribution of nGAP expression
We next determined the tissue distribution of nGAP expres-
sion. On a human tissue RNA blot analysis, we detected 8 kb
nGAP mRNA although the signal was very low in many
tissues (data not shown). Thus, to analyze expression with
greater sensitivity, we performed RT-PCR analysis using
mouse tissue mRNA. To do so, a partial cDNA sequence
information for mouse nGAP (dbEST clone AA107246) was
obtained by searching an EST database. The reported mouse
sequence encoded a peptide consisting of 147 amino acids
showing 100% homology and 99% identity to the residues
240^386 of human nGAP. Using the mouse sequence, oligo-
nucleotide primers were designed and RT-PCR was per-
formed with poly(A) RNA obtained from various mouse
tissues (Fig. 3). The result indicated that nGAP mRNA is
ubiquitously expressed in adult mouse tissues. Furthermore,
RNA derived from brain gave an additional ampli¢ed band.
This suggests the existence of a di¡erentially spliced form of
mRNA or, alternatively, a presence of mRNA that is highly
related to nGAP mRNA in brain tissue.
3.3. E¡ect of nGAP expression on heat shock sensitivity of
ira23 or Ras2Val19 yeast strain
The RasGAP activity of nGAP was next examined by em-
ploying a yeast genetic approach. Yeast S. cerevisiae possesses
two RasGAPs termed Ira1 and Ira2 [15,16]. Genetic disrup-
tion of IRA1 or IRA2 genes increases intracellular levels of
cAMP and, as a result, cells cannot survive following heat
shock treatment. However, ectopic expression of mammalian
RasGAP in ira3 yeast mutants suppresses the elevated Ras
activity and the mutant cells survive after heat shock treat-
ment [16^18].
A genetic rescue experiment was performed in order to
determine whether human nGAP cDNA would alleviate the
heat shock sensitivity of an ira23 yeast strain. As demon-
strated in Fig. 4A, full-length nGAP e⁄ciently complemented
the ira23 mutation with regard to the heat shock resistance.
Next, the nGAP region required for this Ira complementation
was examined by using a series of deletion derivatives. The
smallest region that could rescue ira23 strain was a fragment
encompassing residues 150 and 646 (Fig. 4A). This fragment
covered the entire GRD of nGAP (residues 290^621). How-
ever, further deletions totally lost the ability to complement
yeast Ira2 function in heat shock resistance (data not shown).
The above observation suggested that nGAP functions as a
RasGAP and down-regulates yeast Ras activity by stimulating
GTP hydrolysis. To further pursue this, we examined the ef-
fect of nGAP on constitutively active Ras. A yeast strain
TK161-R2V contains Ras2Val19, which has reduced GTPase
activity and is resistant to RasGAP. As a result, the yeast
strain shows a heat shock sensitive phenotype that is very
similar to that of Ira-de¢cient strains [22]. If nGAP sup-
pressed the heat shock sensitivity of ira23 yeast cells via
mechanisms independent of GTP hydrolysis, then the protein
would also be expected to suppress the heat shock sensitive
phenotype of Ras2Val19 cells. On the other hand, if nGAP
rescued the ira23 phenotype by stimulating GTP hydrolysis
of wild-type Ras, then it should not suppress Ras2Val19 phe-
notype because Ras2Val19 is resistant to RasGAP. We found
that nGAP did not rescue the Ras2Val19 phenotype upon heat
shock treatment of TK161-R2V cells (Fig. 4B). Similarly,
wild-type neuro¢bromin-GRD failed to rescue TK161-R2V
heat shock sensitivity. In contrast, a Phe1434 to Leu mutant
of neuro¢bromin-GRD, NF201, suppressed TK161-R2V heat
shock sensitivity because the mutant molecule interacted with
the e¡ector region of Ras, which is thought to interact with
the downstream Ras e¡ectors, much stronger than the wild-
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Fig. 3. Tissue distribution of nGAP expression. Expression of
nGAP mRNA in various mouse tissues was examined by RT-PCR.
Expected size ampli¢ed from mouse nGAP mRNA was 286 bp (top
row) and the size of genomic DNA ampli¢ed with these primers
was about 1.7 kb (data not shown). Expression of mouse L-actin
mRNA was examined as a control (bottom row).
Fig. 4. Heat shock sensitivity assay with ira23 yeast cells. A: Yeast
transformants derived from ira23 strain that ectopically express
Ira2-GRD, neuro¢bromin (NF1)-GRD, full-length nGAP, nGAP(1^
646) or nGAP(150^646) were heat shock-treated and then incubated
at 30‡C for 4 days. Replica plate that did not receive heat shock
treatment was similarly incubated. B: Yeast strain containing a con-
stitutively active RAS2Val19 was transformed with various yeast ex-
pression vectors for RasGAPs. Three transformants were subjected
to heat shock and then incubated at 30‡C for 4 days.
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type neuro¢bromin-GRD [25]. From these observations, we
concluded that nGAP is capable of functioning as a RasGAP.
3.4. In vitro GAP assay of nGAP
To directly measure the RasGAP activity of nGAP, we
performed in vitro GAP assay with the use of a fusion protein
that contains nGAP (amino acid residues 1^651) linked to
glutathione S-transferase (GST-nGAP). The GST-nGAP fu-
sion protein was found to be biologically active in rescuing
heat shock sensitivity when expressed in ira23 yeast strain
(data not shown). Puri¢cation of the fusion protein was con-
¢rmed by SDS-polyacrylamide gel electrophoresis and subse-
quent gel staining (data not shown). GAP activity of GST-
nGAP was tested using [Q-32P]GTP-loaded H-Ras, R-Ras,
Rap1 or Ral protein prepared in bacteria as substrates.
GTP hydrolysis was monitored by using a ¢lter binding assay.
Control experiments employing Gap1m exhibited GTP hydrol-
ysis on H-Ras and R-Ras but not on Rap1B and Ral as
described previously [23]. In contrast, nGAP failed to exhibit
signi¢cant GAP activity toward any of the examined low mo-
lecular weight GTPases under the conditions tested (Fig. 5).
3.5. Chromosomal mapping
Chromosomal localization of the nGAP gene was deter-
mined by £uorescence in situ hybridization (FISH) on normal
human metaphase chromosomes using full-length nGAP
cDNA as a probe. As shown in Fig. 6, clear discrete signals
on both homologues were observed in chromosome 1q25, the
region where linkage of a major susceptibility locus to pros-
tate cancer has been recently reported [26,27].
4. Discussion
In this work, we describe the molecular cloning of a human
cDNA whose product possesses the GAP-related domain
(GRD) that is strongly conserved among all known Ras-
GAPs. The GRD is considered to be indispensable for Ras-
GAPs to activate Ras GTPase activity. Mutational studies of
GRD revealed the invariable conservation of several critical
amino acids that are needed for Ras binding and for activat-
ing Ras GTPase activity [28^31]. In particular, Phe-Leu-Arg-
Phe-x-x-Pro-Ala-Ile-x-x-Pro (where x is any amino acid) is the
most conserved GRD motif and is present in the nGAP-
GRD. Furthermore, structure-function analyses have revealed
that three amino acids (Arg786, Lys831, and Arg925 that corre-
spond to Arg789, Lys834, and Arg928 in human p120GAP) in
GRD are required for binding of p120GAP to GTP-bound
Ras [31]. In addition, mutation of Lys1423 in neuro¢bromin to
Glu or Gln that was detected in patients with colon cancer
and anaplastic astrocytoma [32] was suggested to a¡ect the
catalytic activity rather than the binding of Ras to neuro¢-
bromin. All of these functionally critical amino acids are con-
served in GRD of human nGAP (Arg369, Lys414, Arg505,
Lys512).
The predicted amino acid sequence strongly suggests that
the newly isolated nGAP is a member of RasGAPs. Indeed,
expression of nGAP in yeast demonstrated that the protein
was capable of rescuing a heat shock sensitive phenotype as-
sociated with the lack of yeast RasGAP. Consistently, loss of
GAP-2, the C. elegans homologue of nGAP, suppressed the
larval lethality caused by reduced LET-60 Ras activity [21],
indicating that GAP-2 is capable of functioning as a RasGAP
in vivo and negatively regulates the LET-60 Ras signalling
pathway. Despite extensive e¡ort, however, highly puri¢ed
recombinant nGAP proteins did not show any in vitro GAP
activity toward several low molecular weight GTPase proteins
such as H-Ras, R-Ras, Rap1B and Ral. The result suggests
that nGAP speci¢cally targets other members of Ras family
proteins or low molecular weight GTPases that contain e¡ec-
tor domains highly similar to Ras [33^35].
Finally, nGAP gene was assigned to the human chromo-
FEBS 21279 14-12-98
Fig. 5. In vitro GAP assay of nGAP. GAP activity of GST-
nGAP(1^651) or Gap1m was examined with the use of [Q-32P]GTP-
loaded H-Ras, R-Ras, Rap1B or Ral as a substrate (17 ng per as-
say). Radioactivity remaining on the ¢lters after 10 min was deter-
mined. The amount of [Q-32P]GTP-loaded substrates of samples kept
on ice was taken as 100%.
Fig. 6. Fluorescence in situ hybridization mapping of the nGAP
gene. A full-length human nGAP cDNA was hybridized to normal
human chromosomes as described previously [33]. A metaphase
chromosome spread from a single cell counterstained with DAPI
and showing nGAP signal on the chromosome 1q25 (arrows).
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some 1q25 by FISH. Furthermore, gene map analysis of hu-
man genome with the resources of the National Center for
Biotechnology Information revealed that nGAP gene (human
sequence tagged site (STS) WI-30983 that contains 314 bp 3P
non-coding region of nGAP) is mapped to the locus between
markers D1S218 and D1S466 on chromosome 1q24-25. Intri-
guingly, the chromosome locus has been recently proposed to
contain a putative hereditary prostate cancer susceptible gene
(HPC1) by genome-wide linkage analysis [26,27]. Since nGAP
appears to encode a RasGAP as is the case of NF1 tumor
suppressor gene, the chromosomal assignment raises an intri-
guing possibility that nGAP is the proposed HPC1 gene
whose malfunctioning is involved in the development of pros-
tate cancer.
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